Anna-Maria Hoffmann-Vold, M.D. Ph.D.

Dr. Anna-Maria Hoffmann-Vold serves as the Head of the Inflammatory and Fibrotic Rheumatic Disease Research Area at Oslo University Hospital and leads the translational research at University Hospital Zurich. She is also the chair of the comorbidity research in rheumatic diseases at the REMEDY center in Oslo. As a senior consultant, she specializes in the care of patients with systemic sclerosis (SSc) and interstitial lung disease (ILD) associated with various rheumatic diseases. Prof. Hoffmann-Vold is the convenor of the ERS/EULAR guidelines for connective tissue diseases (CTD) associated ILD (CTD-ILD) and chairs the EULAR study group focusing on lung involvement in rheumatic and musculoskeletal diseases.

Her primary expertise and interests lie in clinical and translational research on SSc and other CTDs, particularly concerning ILD and pulmonary arterial hypertension. She is committed to developing management recommendations and conducting clinical trials in these areas.